COVID-19 NEWS
PEI-NI JONE, MD
Director of 3D Echocardiography, Director of Kawasaki Disease Clinic, Director of Quality in Echocardiography, Children’ s Hospital Colorado
Professor, Pediatrics-Cardiology, University of Colorado School of Medicine
CHRISTINA OSBORNE, MD
Fellow, Critical Care, Children’ s Hospital Colorado
Clinical Instructor, Pediatrics, University of Colorado School of Medicine
The Case for Two
Would kids diagnosed with MIS-C do better with more aggressive treatment up front?
SAMUEL DOMINGUEZ, MD, PHD
Pediatric Infectious Diseases, Children’ s Hospital Colorado
Professor, Pediatrics- Infectious Diseases, Course Director, Microbiology, Rounds Leader, Global Health and Disaster Course, University of Colorado School of Medicine
More than 50 years after Kawasaki disease was first described, nobody knows quite what causes it or why it happens in previously healthy children. The same is true of multi-inflammatory syndrome in children, or MIS-C, which investigators linked to SARS-CoV-2 infection in early 2020. It was clear right away the two conditions had a lot in common, and so it made sense to treat them in much the same way. But Kawasaki disease experts like pediatric cardiologist Pei-Ni Jone, MD, and pediatric infectious disease specialist Samuel Dominguez, MD, quickly noticed a key difference: kids with MIS-C were sicker.
10 | CHILDREN’ S HOSPITAL COLORADO